Evidence map›Paper›PMID 39697705›Full record

ArticleTranslational cancer research2024

Jing Zhao, Yue Cui, Hua Zhou, Dongming Zhou, Zhiping Che, Ning Zhang, Qi Yun, João Agostinho Machado-Neto, Daniela Damiani, Lika'a Fasih Y Al-Kzayer and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Translational cancer research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jing ZhaoDepartment of Pediatrics, Changzhou Children's Hospital Affiliated to Nantong University, Changzhou, China.
Yue CuiDepartment of Laboratory Medicine, Changzhou Children's Hospital Affiliated to Nantong University, Changzhou, China.
Hua ZhouDepartment of Pediatrics, Changzhou Children's Hospital Affiliated to Nantong University, Changzhou, China.
Dongming ZhouDepartment of Laboratory Medicine, Changzhou Children's Hospital Affiliated to Nantong University, Changzhou, China.
Zhiping CheDepartment of Laboratory Medicine, Changzhou Children's Hospital Affiliated to Nantong University, Changzhou, China.
Ning ZhangDepartment of Laboratory Medicine, Changzhou Children's Hospital Affiliated to Nantong University, Changzhou, China.
Qi YunDepartment of Laboratory Medicine, Changzhou Children's Hospital Affiliated to Nantong University, Changzhou, China.
João Agostinho Machado-NetoDepartment of Pharmacology, Institute of Biomedical Sciences, University of São Paulo (USP), São Paulo, Brazil.
Daniela DamianiDivision of Hematology and Stem Cell Transplantation, Department of Medicine, University of Udine, Udine, Italy.
Lika'a Fasih Y Al-KzayerDepartment of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan.
Rohan KulkarniHuntsman Cancer Institute at the University of Utah, Salt Lake City, UT, USA.
Meng GuDepartment of Laboratory Medicine, Changzhou Children's Hospital Affiliated to Nantong University, Changzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The use of FMS-like tyrosine kinase 3 ( Methods: The Cancer Genome Atlas (TCGA) and Genotype-Tissue Expression (GTEx) databases were used to identify the ICMs associated with Results: Absent in melanoma 2 ( Conclusions: Our study identified

Indexed as

absent in melanoma 2 (AIM2)Acute myeloid leukemia (AML)FMS-like tyrosine kinase 3 (FLT3)immune checkpointimmune infiltration

Identifiers

PMID39697705
PMCPMC11651761

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.